First Look at Roche/Genentech’s Gazyva Shows Strong Early Enthusiasm in Lupus Nephritis Launch, According to Spherix Global Insights
EXTON, PA, Nov. 19, 2025 (GLOBE NEWSWIRE) — Spherix Global Insights has released the first wave of Launch Dynamix(TM): Gazyva in Lupus Nephritis, providing the earliest independent read on the commercial introduction of Gazyva(R) (obinutuzumab, Genentech/Roche). The monthly service benchmarks uptake, perceptions, and key performance metrics during the first 18 months of launch, supplemented by […]